Inmunotek is a Spanish pharmaceutical company, founde in 1992, which researches, develops, manufactures and markets products (medicines and medical devices) for allergy and immunology, both for human and veterinary medicine.
Inmunotek's mission is to improve the quality of life of patients and to provide value to healthcare professionals. Today, our multidisciplinary team spans across 63 countries.
Inmunotek carries out clinical trials (phases I, II, III, and IV) globally to evaluate the safety and efficacy and effectiveness of the products.
Inmunotek's clinical development program is extensive and encompasses both allergen and bacterial immunotherapy products.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.